The Oncotect test is a cutting-edge cancer screening solution for dogs, developed by a team of highly qualified veterinarians, scientists, and pet advocates.

As a non-invasive, highly accurate, and affordable screening test, it offers a convenient and proactive approach to screening cancer risks in dogs. The test identifies the presence of cancer-associated volatile metabolites, providing veterinary professionals and pet owners with the information they need to make informed decisions about their pet's health.

With its unique multi-cancer capabilities, the Oncotect test is a valuable tool for early cancer detection and improved outcomes for dogs.

The Oncotect test is a non-invasive cancer screening test for dogs that assesses the presence of cancer-associated volatile metabolites.

The test results are presented as three levels of cancer risk: low, moderate, or high. It is important to note that while the test provides an indication of cancer risk, it does not diagnose a specific type of cancer.

Further diagnostic tests and evaluations by a veterinarian are necessary to determine the type and extent of cancer in a dog with a positive result.

The Oncotect test has been clinically proven to be highly accurate in detecting the presence of cancer-related volatile metabolites in dogs.

With a sensitivity of 83% and a specificity of 96% among the four most common canine cancer types (melanoma, lymphoma, mast cell tumor, and hemangiosarcoma), the Oncotect test offers a level of accuracy that is on par with or better than other available cancer screening tests for dogs.

This high level of accuracy makes the Oncotect test a valuable tool for veterinary professionals and pet owners who are looking to detect cancer risks early and improve the health outcomes for affected animals.

By detecting cancer-related metabolites in the urine, the Oncotect test can provide critical information for making informed decisions about treatment and care, helping to ensure the best possible outcome for dogs with cancer.

Early cancer screening can have several benefits for dogs and their owners, including improved treatment options, reduced stress and anxiety, improved quality of life and cost savings. To learn more, read out post The Benefits of Screening for Cancer Risks Early.

The Oncotect test is a multi-cancer screening solution that can detect various types of cancer-associated volatile metabolites in dogs. Currently, it has been proven to effectively detect cancers such as mast cell tumors, hemangiosarcoma, lymphoma, and melanoma.

The test is constantly being improved and refined, with further types of cancers being studied and tested to expand its capabilities.

By using the latest advancements in veterinary science, the Oncotect test provides pet parents and veterinary professionals with a reliable tool for early cancer detection and improved health outcomes for dogs.

The Oncotect test offers a unique advantage by allowing for the early detection of cancer risks, even before any clinical signs are noticeable.

By identifying the presence of cancer-associated volatile metabolites, the test provides valuable information about a dog's health, enabling pet owners and veterinary professionals to take a proactive approach to diagnosing and treating cancer.

This early detection can improve the chances of successful treatment and lead to better health outcomes for dogs.

Delayed cancer diagnosis can have serious consequences, including a reduced survival rate and increased treatment complications.

By detecting cancer early, the Oncotect test provides a crucial opportunity for effective and timely action. Early cancer diagnosis can lead to a wider range of treatment options, improved quality of life, and better health outcomes for dogs.

The Oncotect test empowers pet owners and veterinary professionals to take a proactive approach to cancer diagnosis and treatment, helping to ensure the best possible outcome for dogs with cancer.

Clinical signs of cancer in dogs can vary depending on the type and location of the cancer, but some common signs include:

• Lumps or masses under the skin
• Abdominal swelling or growths
• Sores that do not heal
• Loss of appetite or sudden weight loss
• Changes in behavior or activity level
• Persistent coughing or trouble breathing
• Changes in eating or drinking habits
• Difficulty urinating or defecating
• Lameness or stiffness
• Bleeding or discharge from any body opening

It is important to note that these signs can also be indicative of other health problems and not necessarily cancer.

It is always best to consult a veterinarian if you notice any changes in your dog's behavior or health.

If the results of the Oncotect test indicate low cancer risk, it is a positive sign that the test is detecting low levels of cancerous volatile metabolites among the 4 cancers.

This is a cause for relief and peace of mind for pet owners. To maintain ongoing monitoring of your dog's health, we recommend repeating the Oncotect test annually as part of a proactive cancer screening program.

Regular testing can help to detect any changes in cancer risk over time and ensure that any necessary treatments are started as early as possible.

By taking a proactive approach to cancer screening, pet owners can help to ensure the best possible health outcomes for their dogs.

If the Oncotect test results indicate moderate cancer risk, it means that moderate levels of cancer-associated volatile metabolites have been detected in your dog's urine.

In such cases, it is important to closely monitor your dog's health and consider additional diagnostic tests.

If there are no other clinical signs of cancer and the risk value is below 0.06, we recommend repeating the Oncotect test in three months to closely monitor any changes in cancer risk or talk to your veterinarian for further testing recommendations.

If the risk value is above 0.06 and there are other clinical signs of cancer, it is imperative to take your dog to a veterinarian for additional diagnostic tests to confirm or rule out the presence of cancer.

Early detection and prompt action can greatly improve the chances of successful treatment and a positive outcome for your dog.

If the Oncotect test results indicate high cancer risk, it indicates the presence of elevated levels of cancer-associated volatile metabolites in your dog's urine.

In such cases, it is important to take prompt action to determine the presence of cancer and begin treatment as early as possible.

We strongly recommend taking your dog to a veterinarian for additional diagnostic tests to confirm or rule out the suspicion of cancer.

Early detection and prompt action can greatly improve the chances of successful treatment and a positive outcome for your dog.

By working closely with a veterinarian, pet owners can ensure that their dog receives the best possible care and support during this time.

The Oncotect test has demonstrated effective and reliable results in dogs and is currently available for their use.

Our team is committed to expanding our diagnostic services and is actively working to extend our offerings to include cats and horses in the near future.

This will allow us to provide a comprehensive and convenient solution for the early detection of cancer in a wider range of companion animals, helping to improve their health outcomes and quality of life.

The Oncotect test offers pet owners the convenience of either in-clinic testing at an animal hospital or an easy-to-use at-home option.

The at-home test does not require a veterinary exam, making it a convenient and accessible option for pet owners.

However, it is important to note that while the at-home test provides valuable information, it is recommended to share the results with a trusted veterinarian.

This helps to ensure that your dog receives the most appropriate care and treatment, taking into account their individual needs and health status.

At Oncotect, we understand the importance of the veterinary client-patient relationship and believe that working with a knowledgeable veterinarian is key to promoting the health and well-being of your pet.

The Oncotect test is a highly regarded and scientifically sound cancer screening solution for dogs, with widespread approval and acceptance among veterinarians.

Available at veterinary hospitals, the test has been designed to diagnose early-stage cancer in dogs, providing pet owners and veterinary professionals with valuable information about their dog's health.

With its veterinarian-approval and solid scientific foundation, the Oncotect test is a trusted and reliable tool for early cancer detection and improved health outcomes for dogs.

The Oncotect test is encouraged for all ages as a proactive and preventative measure, ESPECIALLY for older dogs

As dogs reach the age of 10, they have a 50% chance of developing cancer, making early detection and monitoring critical to their health.

By taking a proactive approach to cancer screening, pet owners can help to ensure the best possible health outcomes for their dogs and promote their well-being.

The coverage of diagnostic tests by pet insurance companies can vary greatly.

While it is difficult to say for certain, if a pet insurance company covers similar diagnostic tests, it is possible that they may also cover the Oncotect test.

However, it is important to carefully review the terms and conditions of your pet insurance policy and to confirm coverage with your insurance company prior to undergoing the test.
By doing so, you can ensure that you have a clear understanding of what is covered and what expenses may be incurred.

The Oncotect test requires a urine sample, which can be collected using either the free flow catch or cystocentesis method.

For those collecting a urine sample at home, the process is simple and straightforward, regardless of whether you have a male or female dog.

To collect a urine sample, take your dog outside on a short leash and be ready with the provided paper tray.

For male dogs, gently and swiftly place the tray under the stream when they lift their leg.

For female dogs, slowly approach as they begin to squat and place the tray under them to catch the mid-stream sample. It is important to wear rubber gloves to maintain hygiene and prevent contamination of the sample.

After collection, remember to wash your hands thoroughly. Using the provided pipette, transfer the urine to a collection tube with a lid and freeze it immediately to preserve the integrity of the sample. This will help ensure accurate results from the Oncotect test.

Immediately after collecting the sample, it is important to transfer 1-2 ml of urine to the preservative collection tube.

This helps to ensure the accuracy and reliability of the test results by preserving the volatile organic compounds (VOCs).

All returns must be packaged using the Oncotect's shipping container and pre-printed label.

This will help to ensure accurate and reliable test results by keeping the samples stable and safe during transportation.